Farallon Capital Management’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$234K Sell
2,800
-2,200
-44% -$181K ﹤0.01% 131
2025
Q4
$458K Hold
5,000
﹤0.01% 97
2025
Q3
$474K Sell
5,000
-314,800
-98% -$29.6M ﹤0.01% 94
2025
Q2
$33.5M Sell
319,800
-102,000
-24% -$9.67M 0.14% 61
2025
Q1
$37.3M Buy
421,800
+419,000
+14,964% +$43M 0.18% 63
2024
Q4
$269K Hold
2,800
﹤0.01% 118
2024
Q3
$229K Hold
2,800
﹤0.01% 137
2024
Q2
$241K Hold
2,800
﹤0.01% 126
2024
Q1
$229K Buy
+2,800
New +$219K ﹤0.01% 143
2023
Q4
Sell
-2,800
Closed -$205K 164
2023
Q3
$205K Buy
+2,800
New +$189K ﹤0.01% 127

Other funds holding HQY

Farallon Capital Management's HQY Position: Q1 2026 in Review

Farallon Capital Management reduced its HealthEquity (HQY) stake by 44% in Q1 2026, selling an estimated $181K and leaving 2,800 shares worth $234K. The position accounts for ﹤0.01% of the portfolio, ranked #131.

Farallon Capital Management first reported a position in HQY in Q3 2023 and has held it in 10 quarters since. The position peaked at $37.3M in Q1 2025. 485 funds tracked by Wall St. Rank hold HQY as of Q1 2026.

  • Farallon Capital Management held 2,800 shares of HealthEquity worth $234K as of Q1 2026.
  • Farallon Capital Management sold 2,200 HealthEquity shares in Q1 2026, an estimated $181K.
  • HealthEquity made up ﹤0.01% of Farallon Capital Management's portfolio in Q1 2026, its #131 holding.
  • Farallon Capital Management first reported a position in HealthEquity in Q3 2023 and has held it in 10 quarters since.
  • Farallon Capital Management's HealthEquity position peaked at $37.3M in Q1 2025.
  • 485 funds tracked by Wall St. Rank held HealthEquity as of Q1 2026.

Based on Farallon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.